The global transfection reagents & equipment market size is expected to reach USD 1.4 billion by 2025, expanding at a CAGR of 7.7%, according to a new report by Grand View Research, Inc. The latest polymeric formulations-based compounds are gentle to cells as compared to cationic liposomes and these products render higher gene-delivery efficiency, further promoting the development of unique transfection products in the market.
Transfection Reagents & Equipment Market Report Highlights
- The reagents segment accounted for the highest revenue of USD 465.9 million in 2019 and is anticipated to maintain this trend throughout the forecast period
- This is attributed to the heavy investments by manufacturers including F. Hoffmann-La Roche AG in the development of multicomponent-based products
- Lipofection is emerging as a lucrative technique, which can be attributed to its wide acceptance across sequential, reverse, multiple, transient, and co-transfection
- Moreover, high protocol variability allows lipofection to be used for transfection of all types of nucleic acids and also contributes to the revenue generation by this segment
- Biomedical research includes the application of transfection reagents across mutational analysis, library screening, and preclinical testing. This segment is estimated to witness the fastest growth rate of more than 8.0% during the study period
- North America generated maximum revenue of 40.0% in 2019 attributed to the sufficient presence of skilled professionals along with the strong network of original equipment manufacturers
- Market participants are keen on expanding their product portfolios aimed at sustaining market competition
- For instance, in July 2019, Mirus Bio launched TransIT-VirusGEN SELECT Transfection Reagent, intended to be used in the drug discovery process in gene and cell manufacturing. The substance simplifies the qualifying process of ancillary materials employed in viral vectors manufacturing for preclinical and early-phase clinical trials.
Gain deeper insights on the market and receive your free copy with TOC now @: Transfection Reagents & Equipment Market Report
Transfection is a fundamental technique used in molecular biology to introduce foreign nucleic acids, such as DNA or RNA, into cells for various applications such as gene expression analysis, protein production, and genome editing. Transfection reagents and equipment are essential components of this process, providing the necessary tools to facilitate efficient and specific delivery of nucleic acids to cells. The reagents used in transfection include cationic lipids, polymers, and nanoparticles, which can effectively interact with the nucleic acids and mediate their delivery into cells. Equipment such as electroporators, microinjectors, and gene guns can also be used to introduce nucleic acids into cells with varying levels of efficiency and specificity. The choice of transfection reagent and equipment is dependent on the cell type, nucleic acid type, and desired outcome of the experiment. Thus, careful consideration should be given to these factors when selecting transfection reagents and equipment.
Transfection Reagents & Equipment Market Trends
The transfection reagents and equipment market has been rapidly expanding in recent years, driven by the increasing demand for gene therapy and genome editing applications. One of the latest developments in the market is the introduction of CRISPR/Cas9-based transfection reagents, which can specifically target and edit genes with high efficiency and accuracy. These reagents have shown great promise in treating genetic diseases and cancers. Another significant development is the emergence of nanoparticle-based transfection reagents, which can deliver nucleic acids to cells more efficiently than traditional methods. These reagents have a lower toxicity profile and can target specific cell types or tissues, allowing for more precise and effective delivery of therapeutics. In addition, the demand for automated transfection equipment has been increasing, as it can streamline and simplify the transfection process, reducing the potential for human error and increasing throughput. Several companies have introduced automated transfection systems that can perform high-throughput transfections in a variety of cell types.
Moreover, multi-component reagents such as X-tremeGENE provided by F. Hoffmann-La Roche AG, deliver high efficiency and minimal cytotoxicity than traditional ones comprising only one-component formulations. Thus, companies are keen on offering cutting-edge transfection solutions, in turn, offering significant momentum to market growth.
The gene expression studies segment dominated the market and account for the largest revenue share in 2019. This is attributed to the rising focus on the translation of genomic information in clinics. In addition, an increasing number of research projects related to the identification of chromosomal anomalies is anticipated to propel segment growth.
Transfection Reagents & Equipment Market Insights By Region
North America generated the largest revenue share. The region is anticipated to maintain this trend throughout the forecast period. This is attributed to the presence of well-established manufacturers and robust funding to promote R&D on cancer therapeutics, precision medicine, and advanced cytological studies. In Asia Pacific, a growing patient pool and subsequent untapped market potential, along with the growing healthcare expenditure, are expected to create a favorable environment for established international manufacturers looking to expand their business of transfection reagents and equipment. This is also supplemented by active government participation targeted towards promoting the use of cell and gene therapy.
Competitive Analysis By Major Players
Several strategic initiatives including portfolio expansions through novel product launches have been adopted by key players to maintain their presence in the market for transfection reagents and equipment. Some of the prominent players in the transfection reagents & equipment market include:
- Thermo Fisher Scientific, Inc.
- Promega Corporation
- Lonza
- QIAGEN
- Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories Inc.
- Merck KGaA
For More Details or Sample Copy please visit link @: https://www.grandviewresearch.com/industry-analysis/transfection-reagents-and-equipment-market/request/rs1
Grand View Research has segmented the global transfection reagents and equipment market on the basis of product, method, application, and region.
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
For Customized reports or Special Pricing please visit @: https://www.grandviewresearch.com/inquiry/2331/ibb
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll-Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com